Rainer,
This sold off at the EOY for no reason except manipulation by those who wanted cheap shares.
Holding every share - in fact I have 50K shares more now that I bought when it went down at the end of 2016 for a total of 300K shares.
Yesterday's conference probably went off very well and may be the big investors there were encouraged by the CEO's presentation and the meeting afterwards.
Long and Strong
This sold off at the EOY for no reason except manipulation by those who wanted cheap shares.
Holding every share - in fact I have 50K shares more now that I bought when it went down at the end of 2016 for a total of 300K shares.
Yesterday's conference probably went off very well and may be the big investors there were encouraged by the CEO's presentation and the meeting afterwards.
Long and Strong
Recent HEPA News
- Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma • GlobeNewswire Inc. • 03/03/2026 12:35:00 PM
- Hepion Pharmaceuticals Successfully Completes Application to the OTCQB • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer • GlobeNewswire Inc. • 06/16/2025 12:30:00 PM
